| Tag | Content |
|---|
EnhancerAtlas ID | HS113-11282 |
Organism | Homo sapiens |
Tissue/cell | Keratinocyte |
Coordinate | chr14:60617570-60619600 |
Target genes | |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| FOXP1 | MA0481.2 | chr14:60618016-60618028 | GAGTAAACAGAA | + | 6.27 | | POU4F2 | MA0683.1 | chr14:60619174-60619190 | ATGCATATATAATTAG | + | 6.75 | | TFAP2A | MA0003.3 | chr14:60618663-60618674 | TGCCTGAGGCT | - | 6.32 |
|
| | Number of super-enhancer constituents: 2 | ID | Coordinate | Tissue/cell |
| SE_23029 | chr14:60617334-60624391 | CD8_primiary | | SE_51596 | chr14:60617529-60620224 | Skeletal_Muscle |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 5 | Chromosome | Start | End |
| chr14 | 60619069 | 60619215 | | chr14 | 60618583 | 60618767 | | chr14 | 60617617 | 60617735 | | chr14 | 60619244 | 60619363 | | chr14 | 60618283 | 60618977 |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH14I060150 | chr14 | 60617512 | 60619928 |
|
Enhancer Sequence | GTGAGGGGTC TTCCCATCAA TGATTTTTAT GGTAGGCATG CACTGGATAG GTAAAAAGAA 60
CTATCCCTAT AGATTCTGAT ATATGCTCTT CATACCAGTC CTCCTCTCCC CACTCCAAAA 120
GGGGTATATG TCCTCCACTG AGAATCACTG AGGTCAGGTT TCTATTTATT CCCCAAAGTA 180
GTCTAAAGTG CAAATTTTTG GGGCAAAGGT GAGGAAGATG GGATTAGTAC TTCACAGAAA 240
GTATCAGAAA GAATGAATTC AACTTTTTCC ATTTATATTT CTATTTTAAC AGTATTAATT 300
CATTTTAGCA AACATTTATC TTTTTGGGTA ATAAGAGGGT ATGTGGCTAA TTAAAAATGT 360
AATATGATTG CCTACTGAAT GACTTGTGTA AAACAGACTA GACCTTCTAG ACTTAAAAAG 420
ATACTGACCA TTTCTAAACC AATGGGGAGT AAACAGAAAT CTACTGCCTC TCATCTCTTC 480
CTAAATTAGG AAATGTTCCA AGACTACATT GTTATAAGGC TGGGTTATCT ATTGAAAAGC 540
CTAAACAGCT AACCCACAGT ACATTGTATA TGATCCAAAA ATGTTAAACA GTTATCAGCT 600
CTGAAATGCT GACCCCAACA AACAGAGGGG CTATGAGGGT TTATGATCAG AGACCAATAC 660
AGTGCCAGAC TCAGAGATGA ACCCAAAAAA AAAAAAAAAG CTTGCTAATT GAATGGAAAA 720
CTCCCATAAC TTTAACCTTC TGCCTCTCTG TAGCAAAAGA GGAGAGAGGA CACCAAGCAA 780
GCCAATATAT CAAACACTAA AACCTCTCCT TGTTTGAAAT CACATCTAGT ATTGTGTGTA 840
AACTTTTCAA TGATAAACAA GTTAATTCTG TAGTTTACTG AGAATCTGAG AAGGAAATGT 900
GCTCTTCAAA AAGAGCTTCC TGGTAACTAC AGTCTCAACC TGCCACATTT TATCATAGGA 960
TCAAATCCAG TAATAAAATA ATGAGTCTTG GAGGGCAGGC CAGACAGCTC ATCTGTGTTT 1020
ACTGAAAGCA TCCAGCATAT CTTATGAGAC ACGTGGTGCC AAACAGATGG GTGGCCGCCC 1080
TCCCTCATCT GCCTGCCTGA GGCTTGCCCA ACTGCTCCAC AGGAAGTGAC TGATGCCTGT 1140
TACTAAATAT GAGGAAATCA TCAGTATAGC ATTCCGCTTC ATCACTGTCT GCAATTGTCT 1200
GCACTTTGCA GCAGAAAAAA GATGTCCTAA AGAACCAAAG CTTCAAATTT TCATGAAACC 1260
ATGATGACCA TGTAGCTATT GCATCTCATG ATTCCAACAG TGAAACATTC TACTTAAACT 1320
GACTTCAACA GCTTTAAATA TAAATTTTGT GTCTTCCTTA ATCATTCTTT TCCTATTGGC 1380
CTTATAATTT CTTTATATCC AGTCTTAAGC CACCATTAAA AATTCATCCA TTTCTAATAT 1440
TTATACATCG TAAGTTATGC AGTCCAAATC AAGCTTCTCT CCTTGCCTCT GCCTTGACTA 1500
GATTTTCTTC TTCCAATGAA ACCAGAGAGA ATACAGTCAA GATTTTTCCC AGTAAGGATA 1560
TGAGACCAGG ACTAATCATC CTGTGGGAAG TACCTATTTC TGACATGCAT ATATAATTAG 1620
ACCAGGCAAA ATAAACACCA ACTACAAGGG GCAAGGAAAA GAAGTCACAG AAATGGGGAG 1680
GAAAAAGTAC ATCCTGAAGT GTATGTAGAA GAAAGGAGAA GTGGACCCCC AATTTTCCAT 1740
GAAGATTTAG TAGGAATAAG GATAAGGTGA AGAGTAACAT GTTAAATAGA TGATACACTT 1800
TTTGAGGGCA GAGACCACAT CTTATTATCT TTATATCCCC AGGGTCTGTT GTAGTACATG 1860
GCACAATGCA GTGCTTGATA CATATTTATT TGTTCAACAA GTTAGAGGCA TGTGTGGATC 1920
AAGTCTTTTT TAGCATCTAC TGGGGGTGTC CTCTACCAAA AGTCTCCTTG GGTCTCTCTG 1980
TCTCCCCACA TCACTTCCAG TTCCAAGGAC CTCACACAGT GATGGCCATA 2030
|
